Disclosure under Regulation 30 of SEBI (LODR) Regualtions, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oxygenta Pharmaceutical Ltd has informed the stock exchange about two key resignations effective 18 August 2025. Mr. Vankineni Sai Sudhakar (DIN: 00733001) stepped down from his dual role as Managing Director and Chief Financial Officer, citing a change in ownership and management of the company. Separately, Mr. Sanagari Kondal Reddy (DIN: 02530466) also resigned as Independent Director for the same reason — a takeover of the company. Both resignations are voluntary and both outgoing directors confirmed there are no other material reasons for their exit. The company is a subsidiary of Virupaksha Organics Limited.
The resignations of the MD, CFO, and an Independent Director — all triggered by a takeover — suggest new management is taking control. Shareholders should expect a Board reconstitution soon and watch for fresh appointments that could signal the new owner's strategic direction for the company.